REPRESENTED BY THE SECRETARY;THE GOVERNMENT OF THE UNITED STATES OF AMERICA; DEPARTMENT OF HEALTH AND HUMAN SERVICES
发明人:
申请号：
EP05750004.3
公开号：
EP1750711B1
申请日:
2005.05.12
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The invention includes methods of neuroprotection, inducing release of neurotrophic factors, inhibiting the over-activation of innate immune cells, attenuating the toxin-induced death and/or damage of tissues, reducing inflammation, treating an inflammation-related condition, and inhibiting NADPH oxidase, that includes contacting or administering an effective amount of at least one compound of the invention that include: valproic acid, sodium butyrate, and salts thereof； opioid peptides； a peptide comprising the tripeptide GGF； and morphinans, such as naloxone, naltrexone, 3-hydroxy-morphinan and dextromethorphan.
